The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma
2.
Surgery may not be necessary to treat invasive breast cancer
3.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
4.
FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.
5.
De-escalation Misses the Mark in Inflammatory Breast Cancer
1.
Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control
2.
A Closer Look at MCV Modules: Features, Functions, and Benefits
3.
Understanding the Causes and Symptoms of Cavernous Sinus Thrombosis
4.
Lactic Acid-Linked lncRNAs in Wilms Tumor: Decoding the Tumor Microenvironment & Prognosis
5.
How Prevident is Revolutionizing Oral Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
Navigating the Complexities of Ph Negative ALL - Part XVI
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation